SEC reporting owner
Atlas Venture Opportunity Fund I, L.P. SEC insider disclosures
| Reporting owner CIK | 0001759241 |
|---|
| Issuers | 14 |
|---|
| Qualifying disclosures | 133 |
|---|
| Public purchases | 9 |
|---|
| Last public filing | 2026-02-10 |
|---|
| Coverage | verified |
|---|
Issuer relationships
- Akero Therapeutics, Inc. (AKRO)
- AVROBIO, Inc. (AVRO)
- Replimune Group, Inc. (REPL)
- Generation Bio Co. (GBIO)
- Magenta Therapeutics, Inc. (MGTA)
- Kymera Therapeutics, Inc. (KYMR)
- Dyne Therapeutics, Inc. (DYN)
- Disc Medicine, Inc. (GMTX, IRON)
- Ikena Oncology, Inc. (IKNA)
- Day One Biopharmaceuticals, Inc. (DAWN)
Recent SEC transactions
No recent published transactions in the current window.
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.